We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Daiichi, Ranbaxy Affirm Merger in Wake of Lawsuit, Potential Congressional Probe
Daiichi, Ranbaxy Affirm Merger in Wake of Lawsuit, Potential Congressional Probe
July 22, 2008
Japanese drugmaker Daiichi Sankyo has reiterated that its merger agreement with India’s Ranbaxy Laboratories is binding despite allegations of fraud and conspiracy made by the U.S. Justice Department.